Use, effectiveness and tolerability of budesonide‐MMX in ulcerative colitis: A real‐life experience-Reference-Cited by-同舟云学术

Use, effectiveness and tolerability of budesonide‐MMX in ulcerative colitis: A real‐life experience

Published:2019-11 Issue:9 Volume:7 Page:1164-1170
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Maconi Giovanni¹,Mezzina Nicolò¹^ORCID,Landi Stefano¹,Grillo Simone¹,Bezzio Cristina²,Bosani Matteo³,Pastorelli Luca⁴,Dell'Era Alessandra¹,Chibbar Richa⁵,Carmagnola Stefania¹,Molteni Paola¹,Cassinotti Andrea¹,Massari Alessandro¹,Ardizzone Sandro¹

Affiliation:

1. Gastroenterology UnitUniversity of MilanMilanItaly

2. Gastroenterology UnitASST RhodenseRho HospitalRhoItaly

3. Gastroenterology UnitGeneral Hospital LegnanoLegnanoItaly

4. Gastroenterology and Digestive Endoscopy UnitUniversity of MilanMilanItaly

5. Division of GastroenterologyBeth Isreal Deaconess Medical CentreBostonUnited States of America

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640619864257

Reference11 articles.

1. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: Current Management;Harbord M;J Crohns Colitis,2017

2. A safety evaluation of budesonide MMX for the treatment of ulcerative colitis

3. Budesonide multi-matrix is efficacious for mesalamine-refractory, mild to moderate ulcerative colitis: A randomized, placebo-controlled trial;Rubin DT;J Crohns Colitis,2017

4. Oral budesonide for induction of remission in ulcerative colitis;Sherlock ME;Cochrane Database Syst Rev,2015

5. Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. Management and treatment optimization of patients with mild to moderate ulcerative colitis;Expert Review of Clinical Immunology;2023-12-07

3. Assessment of the effectiveness of Budesonide MMX® for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study;Gastroenterology Review;2023

4. The combination of sodium alginate and chlorogenic acid enhances the therapeutic effect on ulcerative colitis by the regulation of inflammation and the intestinal flora;Food & Function;2022

5. Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model;International Journal of Biological Macromolecules;2021-12